Form D · Biotechnology
IVIVA Medical, Inc.
Beverly, MA · CIK 0001732139
Offering snapshot reported Mar 26, 2018 · SEC filing
- Reported sold
- Yet to sell Offering amount: $2.05M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 26, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-308527
Source: Form D, filed Mar 26, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Harald C Ott | Director |
| Brock Reeve | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Cummings Center Suite 451 C
Beverly, MA, 01915
Beverly, MA, 01915